Sign in

CIK 0000719135

  • Non-accelerated filer
  • Smaller reporting company

Apyx Medical Corp

Sign in to watch
Ticker
APYX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
112644611
Phone
+1 727-384-2323
Business address
5115 ULMERTON ROAD, CLEARWATER, FL, 33760
Former names
BOVIE MEDICAL CORP, BOVIE MEDICAL Corp, AN CON GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-30 Waldman Lawrence Director Option exercise +12,000 $1.88 $23K 17,338
2026-06-30 Waldman Lawrence Director Shares withheld for taxes −5,024 $4.49 $23K 12,314
2026-06-30 Waldman Lawrence Director Option exercise · Stock option (right to buy) −12,000 0
2026-06-15 Roman Shawn David Chief Operating Officer Option exercise +15,000 $3.23 $48K 15,000
2026-06-15 Roman Shawn David Chief Operating Officer Shares withheld for taxes −10,533 $4.60 $48K 16,467
2026-06-15 Roman Shawn David Chief Operating Officer Option exercise · Stock option (right to buy) −15,000 0
2026-06-11 Levine Wendy Lauren Director Grant or award · Stock Option (Option to Buy) +50,000 50,000
2026-06-11 Vizirgianakis Stavros G. Director Grant or award +450,000 2,196,191
2026-06-11 Goodwin Charles D. II Chief Executive Officer Grant or award · Stock Option (Option to Buy) +213,948 213,948
2026-06-11 Roman Shawn David Chief Operating Officer Grant or award · Stock Option (Option to Buy) +88,044 88,044
2026-06-11 Baylor-Henry Minnie Director Grant or award · Stock Option (Option to Buy) +50,000 50,000
2026-06-11 Waldman Lawrence Director Grant or award · Stock Option (Option to Buy) +50,000 50,000
2026-06-11 HILL MATTHEW C Chief Financial Officer Grant or award · Stock Option (Option to Buy) +132,066 132,066
2026-06-11 CITRONOWICZ MOSHE Sr. V.P. of Operations Grant or award · Stock Option (Option to Buy) +63,392 63,392
2026-03-15 CITRONOWICZ MOSHE Senior Vice President Option exercise +37,000 $1.80 $67K 493,504
2026-03-15 CITRONOWICZ MOSHE Senior Vice President Option exercise · Stock option (right to buy) −37,000 0
2026-01-27 Roman Shawn David Chief Operating Officer Option exercise +12,000 $1.80 $22K 12,000
2026-01-27 Roman Shawn David Chief Operating Officer Option exercise · Stock option (right to buy) −12,000 0
2025-05-15 Waldman Lawrence Director Grant or award · Stock Option (Option to Buy) +30,000 30,000
2025-05-15 Vizirgianakis Stavros G. Director Grant or award · Stock Option (Option to Buy) +128,000 128,000

Page 1 of 13 · 250 trades